<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_kounis" title="Contrast Media Induced Kounis Syndrome: A Case Report" shortTitle="kounis" author="Da-Sen Chien, Andy  Po-Yi Tsai, Po-Chen Lin, Giou-Teng Yiang, Meng-Yu Wu" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2075-4418/9/4/154/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
3.	LS	3.
Discussion	NN	discussion
</s>
</head>
<p>
<s type="decl">
Kounis	NNP	Kounis
syndrome	NN	syndrome
is	VBZ	be
defined	VBN	define
as	IN	as
acute	JJ	acute
coronary	NN	coronary
syndromes	NNS	syndrome
(	-LRB-	(
ACS	NNS	ACS
)	-RRB-	)
induced	VBN	induce
by	IN	by
hypersensitivity	NN	hypersensitivity
and	CC	and
anaphylactic	JJ	anaphylactic
reaction	NN	reaction
.	.	.
</s>
<s type="decl">
Several	JJ	several
causes	NNS	cause
are	VBP	be
reported	VBN	report
to	TO	to
induce	VB	induce
Kounis	NNP	Kounis
syndrome	NN	syndrome
,	,	,
such	JJ	such
as	IN	as
medicines	NNS	medicine
,	,	,
environmental	JJ	environmental
exposures	NNS	exposure
,	,	,
bee	NN	bee
stings	NNS	sting
,	,	,
and	CC	and
asthma	NN	asthma
(	-LRB-	(
Table	NNP	Table
2	CD	2
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Ayhan	NNP	Ayhan
Akoz	NNP	Akoz
et	FW	et
al.	NNS	al.
conducted	VBD	conduct
a	DT	a
prospective	JJ	prospective
study	NN	study
and	CC	and
found	VBD	find
the	DT	the
incidence	NN	incidence
of	IN	of
Kounis	NNP	Kounis
syndrome	NN	syndrome
in	IN	in
all	DT	all
admissions	NNS	admission
to	TO	to
be	VB	be
19.4/100,000	CD	19.491000000
.	.	.
</s>
<s type="decl">
The	DT	the
most	RBS	most
common	JJ	common
etiology	NN	etiology
reported	VBN	report
was	VBD	be
the	DT	the
use	NN	use
of	IN	of
medications	NNS	medication
,	,	,
accounting	VBG	account
for	IN	for
about	RB	about
81	CD	81
%	NN	%
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
current	JJ	current
concept	NN	concept
,	,	,
three	CD	3
variants	NNS	variant
of	IN	of
Kounis	NNP	Kounis
syndrome	NN	syndrome
have	VBP	have
been	VBN	be
described	VBN	describe
.	.	.
</s>
<s type="decl">
Type	NN	type
I	CD	I
variant	NN	variant
is	VBZ	be
characterized	VBN	characterize
by	IN	by
allergy-related	JJ	allergy-related
coronary	NN	coronary
spasm	NN	spasm
without	IN	without
coronary	JJ	coronary
lesions	NNS	lesion
or	CC	or
risk	NN	risk
factors	NNS	factor
.	.	.
</s>
<s type="decl">
Patients	NNS	patient
with	IN	with
type	NN	type
I	CD	I
Kounis	NNP	Kounis
syndrome	NN	syndrome
present	JJ	present
electrocardiographic	JJ	electrocardiographic
change	NN	change
with	IN	with
or	CC	or
without	IN	without
cardiac	JJ	cardiac
enzymes	NNS	enzyme
elevation	NN	elevation
due	JJ	due
to	IN	to
the	DT	the
acute	JJ	acute
release	NN	release
of	IN	of
inflammatory	JJ	inflammatory
mediators	NNS	mediator
inducing	VBG	induce
coronary	JJ	coronary
spasm	NN	spasm
.	.	.
</s>
<s type="decl">
The	DT	the
type	NN	type
II	CD	II
variant	NN	variant
includes	VBZ	include
pre-existing	JJ	pre-exist
atheromatous	JJ	atheromatous
disease	NN	disease
.	.	.
</s>
<s type="decl">
An	DT	a
acute	JJ	acute
allergic	JJ	allergic
reaction	NN	reaction
leading	VBG	lead
to	IN	to
the	DT	the
release	NN	release
of	IN	of
inflammatory	JJ	inflammatory
mediators	NNS	mediator
induces	VBZ	induce
plaque	NN	plaque
erosion	NN	erosion
or	CC	or
rupture	NN	rupture
,	,	,
which	WDT	which
causes	VBZ	cause
acute	JJ	acute
myocardial	JJ	myocardial
infarction	NN	infarction
.	.	.
</s>
<s type="decl">
Type	NNP	Type
III	NNP	III
has	VBZ	have
been	VBN	be
defined	VBN	define
in	IN	in
patients	NNS	patient
with	IN	with
pre-existing	JJ	pre-exist
coronary	JJ	coronary
disease	NN	disease
and	CC	and
coronary	JJ	coronary
artery	NN	artery
stent	NN	stent
thrombosis	NN	thrombosis
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
Jack	NNP	Jack
P.	NNP	P.
Chen	NNP	Chen
et	FW	et
al.	NN	al.
study	NN	study
,	,	,
the	DT	the
pathology	NN	pathology
of	IN	of
drug-eluting	JJ	drug-eluting
stent	NN	stent
(	-LRB-	(
DES	NNP	DES
)	-RRB-	)
thrombosis	NN	thrombosis
in	IN	in
these	DT	this
patients	NNS	patient
presented	VBN	present
with	IN	with
eosinophils	NNS	eosinophil
and	CC	and
mast	NN	mast
cell	NN	cell
infiltration	NN	infiltration
in	IN	in
Giemsa	NNP	Giemsa
and	CC	and
hematoxylin	JJ	hematoxylin
–	SYM	-
eosin	NN	eosin
staining	NN	staining
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
Stéphane	NNP	Stéphane
Cook	NNP	cook
et	NNP	et
al.	NN	al.
study	NN	study
,	,	,
the	DT	the
association	NN	association
with	IN	with
late	JJ	late
DES	NNP	DES
thrombosis	NN	thrombosis
and	CC	and
local	JJ	local
inflammation	NN	inflammation
in	IN	in
histopathology	NN	histopathology
was	VBD	be
reported	VBN	report
.	.	.
</s>
<s type="decl">
In	IN	in
intravascular	JJ	intravascular
ultrasound	NN	ultrasound
analysis	NN	analysis
,	,	,
vessel	NN	vessel
remodeling	NN	remodeling
was	VBD	be
also	RB	also
confirmed	VBN	confirm
.	.	.
</s>
<s type="decl">
Very	RB	very
late	JJ	late
stent	NN	stent
thrombosis	NN	thrombosis
is	VBZ	be
recognized	VBN	recognize
as	IN	as
a	DT	a
feature	NN	feature
of	IN	of
Kounis	NNP	Kounis
syndrome	NN	syndrome
(	:	(
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
5	CD	5
</s>
</figure>
<s type="frag">
)	-RRB-	)
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
detail	NN	detail
pathophysiological	JJ	pathophysiological
mechanisms	NNS	mechanism
remain	VBP	remain
elusive	JJ	elusive
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
current	JJ	current
concept	NN	concept
,	,	,
Kounis	NNP	Kounis
syndrome	NN	syndrome
is	VBZ	be
related	VBN	relate
to	IN	to
inflammatory	JJ	inflammatory
cell	NN	cell
and	CC	and
mast	NN	mast
cell-associated	JJ	cell-associated
disorders	NNS	disorder
.	.	.
</s>
<s type="decl">
Local	JJ	local
inflammatory	JJ	inflammatory
cell	NN	cell
interactions	NNS	interaction
induce	VBP	induce
hypersensitivity	NN	hypersensitivity
and	CC	and
anaphylactic	JJ	anaphylactic
results	NNS	result
by	IN	by
releasing	VBG	release
inflammatory	JJ	inflammatory
mediators	NNS	mediator
after	IN	after
activation	NN	activation
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
Nicholas	NNP	Nicholas
G.	NNP	G.
Kounis	NNP	Kounis
et	FW	et
al.	FW	al.
summary	NN	summary
,	,	,
Kounis	NNP	Kounis
syndrome	NN	syndrome
is	VBZ	be
a	DT	a
complex	JJ	complex
multisystem	NN	multisystem
disease	NN	disease
accompanied	VBN	accompany
by	IN	by
allergy	NN	allergy
–	:	-
hypersensitivity	NN	hypersensitivity
–	:	-
anaphylaxis	NN	anaphylaxis
.	.	.
</s>
<s type="decl">
During	IN	during
hypersensitivity	NN	hypersensitivity
,	,	,
the	DT	the
mast	NN	mast
cells	NNS	cell
and	CC	and
lymphocytes	NNS	lymphocyte
release	VBP	release
inflammatory	JJ	inflammatory
mediators	NNS	mediator
,	,	,
promoting	VBG	promote
an	DT	a
allergic	JJ	allergic
reaction	NN	reaction
via	IN	via
a	DT	a
high	JJ	high
serum	NN	serum
level	NN	level
of	IN	of
histamine	NN	histamine
,	,	,
proteases	NNS	protease
,	,	,
arachidonic	JJ	arachidonic
acid	NN	acid
products	NNS	product
,	,	,
and	CC	and
chemokines	NNS	chemokine
.	.	.
</s>
<s type="decl">
These	DT	this
factors	NNS	factor
cause	VBP	cause
platelet	NN	platelet
aggregating	NN	aggregating
and	CC	and
tissue	NN	tissue
factor	NN	factor
expression	NN	expression
.	.	.
</s>
<s type="decl">
The	DT	the
proteases	NNS	protease
also	RB	also
induce	VBP	induce
plaque	NN	plaque
erosion	NN	erosion
and	CC	and
rupture	NN	rupture
by	IN	by
activating	VBG	activate
matrix	NN	matrix
metalloproteinase	NN	metalloproteinase
(	-LRB-	(
MMP	NNP	MMP
)	-RRB-	)
.	.	.
</s>
<s type="decl">
The	DT	the
downstream	JJ	downstream
mediators	NNS	mediator
induce	VBP	induce
vasoconstriction	NN	vasoconstriction
and	CC	and
worsen	VBP	worse
coronary	JJ	coronary
vasospasm	NN	vasospasm
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
diagnosis	NN	diagnosis
of	IN	of
Kounis	NNP	Kounis
syndrome	NN	syndrome
is	VBZ	be
based	VBN	base
on	IN	on
clinical	JJ	clinical
symptoms	NNS	symptom
and	CC	and
cardiac	JJ	cardiac
surveys	NNS	survey
,	,	,
including	VBG	include
cardiac	JJ	cardiac
enzyme	NN	enzyme
,	,	,
electrocardiographic	JJ	electrocardiographic
,	,	,
echocardiographic	JJ	echocardiographic
,	,	,
and	CC	and
angiography	NN	angiography
.	.	.
</s>
<s type="decl">
The	DT	the
serum	NN	serum
level	NN	level
of	IN	of
tryptase	NN	tryptase
and	CC	and
histamine	NN	histamine
can	MD	can
provide	VB	provide
more	JJR	more
information	NN	information
about	IN	about
the	DT	the
allergic	JJ	allergic
reaction	NN	reaction
(	:	(
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
5	CD	5
</s>
</figure>
<s type="frag">
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Tajda	NNP	Tajda
Keber	NNP	Keber
et	FW	et
al.	FW	al.
suggested	VBD	suggest
measuring	VBG	measure
cardiac	JJ	cardiac
enzymes	NNS	enzyme
in	IN	in
acute	JJ	acute
allergic	JJ	allergic
reaction	NN	reaction
patients	NNS	patient
as	IN	as
necessary	JJ	necessary
to	TO	to
diagnose	VB	diagnose
Kounis	NNP	Kounis
syndrome	NN	syndrome
promptly	RB	promptly
and	CC	and
manage	VB	manage
cardiac	JJ	cardiac
injury	NN	injury
early	RB	early
and	CC	and
appropriately	RB	appropriately
.	.	.
</s>
<s type="sub">
Echocardiography	NN	echocardiography
and	CC	and
coronary	JJ	coronary
angiography	NN	angiography
can	MD	can
provide	VB	provide
detailed	JJ	detailed
information	NN	information
to	TO	to
rule	VB	rule
out	RP	out
takotsubo	NN	takotsubo
cardiomyopathy	NN	cardiomyopathy
or	CC	or
other	JJ	other
cardiac	JJ	cardiac
disorders	NNS	disorder
in	IN	in
cardiac	JJ	cardiac
wall	NN	wall
motion	NN	motion
abnormalities	NNS	abnormality
patients	NNS	patient
.	.	.
</s>
<s type="decl">
Keita	NNP	Keita
Goto	NNP	Goto
et	NNP	et
al.	FW	al.
reported	VBD	report
that	IN	that
thallium-201	NN	thallium-201
(	-LRB-	(
Tl	NNP	Tl
)	-RRB-	)
single-photon	JJ	single-photon
emission	NN	emission
CT	NNP	CT
(	-LRB-	(
SPECT	NNP	SPECT
)	-RRB-	)
and	CC	and
125I-15-(p-iodophenyl)-3-(R	JJ	125I-15-(p-iodophenyl)-3-(R
,	,	,
S)-methylpentadecanoic	NNP	S)-methylpentadecanoic
acid	NN	acid
(	-LRB-	(
BMIPP	NNP	BMIPP
)	-RRB-	)
SPECT	NNP	SPECT
were	VBD	be
conducted	VBN	conduct
in	IN	in
a	DT	a
post-Kounis	JJ	post-Kounis
syndrome	NN	syndrome
patient	NN	patient
,	,	,
and	CC	and
they	PRP	they
revealed	VBD	reveal
a	DT	a
local	JJ	local
perfusion	NN	perfusion
defect	NN	defect
with	IN	with
decreased	VBN	decrease
BMIPP	NNP	BMIPP
uptake	NN	uptake
.	.	.
</s>
<s type="decl">
Aylin	NNP	Aylin
Okur	NNP	Okur
et	FW	et
al.	NN	al.
included	VBD	include
26	CD	26
patients	NNS	patient
with	IN	with
known	VBN	know
or	CC	or
suspected	VBN	suspect
Kounis	NNP	Kounis
syndrome	NN	syndrome
and	CC	and
conducted	VBD	conduct
contrast-enhanced	JJ	contrast-enhanced
magnetic	JJ	magnetic
resonance	NN	resonance
imaging	NN	imaging
.	.	.
</s>
<s type="decl">
The	DT	the
results	NNS	result
revealed	VBD	reveal
an	DT	a
early-phase	JJ	early-phase
subendocardial	JJ	subendocardial
contrast	NN	contrast
defect	NN	defect
and	CC	and
local	JJ	local
edema	NN	edema
in	IN	in
lesion	NN	lesion
areas	NNS	area
in	IN	in
T2-weighted	NN	t2-weighted
images	NNS	image
.	.	.
</s>
<s type="decl">
These	DT	this
newer	JJR	new
images	NNS	image
provide	VBP	provide
a	DT	a
reliable	JJ	reliable
study	NN	study
to	TO	to
assess	VB	assess
cardiac	JJ	cardiac
injury	NN	injury
in	IN	in
Kounis	NNP	Kounis
syndrome	NN	syndrome
.	.	.
</s>
</p>
<p>
<s type="sub">
Compared	VBN	compare
to	IN	to
the	DT	the
majority	NN	majority
of	IN	of
ACS	NNP	ACS
subjects	NNS	subject
,	,	,
the	DT	the
therapeutic	JJ	therapeutic
strategy	NN	strategy
of	IN	of
Kounis	NNP	Kounis
syndrome	NN	syndrome
should	MD	should
focus	VB	focus
on	IN	on
both	CC	both
the	DT	the
cardiac	JJ	cardiac
injury	NN	injury
and	CC	and
allergic	JJ	allergic
reaction	NN	reaction
.	.	.
</s>
<s type="decl">
Sometimes	RB	sometimes
,	,	,
the	DT	the
two	CD	2
different	JJ	different
conditions	NNS	condition
may	MD	may
require	VB	require
opposing	VBG	oppose
treatments	NNS	treatment
.	.	.
</s>
<s type="sub">
In	IN	in
the	DT	the
current	JJ	current
concept	NN	concept
,	,	,
the	DT	the
administration	NN	administration
of	IN	of
medicine	NN	medicine
should	MD	should
avoid	VB	avoid
promoting	VBG	promote
an	DT	a
allergy	NN	allergy
reaction	NN	reaction
and	CC	and
aggravating	VBG	aggravate
the	DT	the
cardiac	JJ	cardiac
injury	NN	injury
.	.	.
</s>
<s type="decl">
Intravenous	JJ	Intravenous
corticosteroids	NNS	corticosteroid
(	-LRB-	(
hydrocortisone	NN	hydrocortisone
:	:	:
1	CD	1
–	SYM	-
2	CD	2
mg/kg/day	NN	mg/kg/day
)	-RRB-	)
and	CC	and
antihistamine	NN	antihistamine
agents	NNS	agent
(	-LRB-	(
diphenhydramine	NN	diphenhydramine
:	:	:
1	CD	1
–	SYM	-
2	CD	2
mg/kg	NN	mg/kg
)	-RRB-	)
are	VBP	be
useful	JJ	useful
to	TO	to
control	VB	control
the	DT	the
allergic	JJ	allergic
reaction	NN	reaction
.	.	.
</s>
<s type="decl">
Aspirin	NN	Aspirin
is	VBZ	be
,	,	,
however	RB	however
,	,	,
potentially	RB	potentially
detrimental	JJ	detrimental
because	IN	because
of	IN	of
cyclooxygenase	NN	cyclooxygenase
inhibition	NN	inhibition
,	,	,
promoting	VBG	promote
arachidonic	JJ	arachidonic
acid	NN	acid
release	NN	release
into	IN	into
the	DT	the
leukotriene	NN	leukotriene
pathway	NN	pathway
.	.	.
</s>
<s type="decl">
Calcium	NN	Calcium
channel	NN	channel
blockers	NNS	blocker
and	CC	and
nitrates	NNS	nitrate
can	MD	can
relieve	VB	relieve
the	DT	the
vasospasm	NN	vasospasm
.	.	.
</s>
<s type="sub">
In	IN	in
hemodynamically	RB	hemodynamically
unstable	JJ	unstable
patients	NNS	patient
,	,	,
nitrates	NNS	nitrate
may	MD	may
not	RB	not
be	VB	be
appropriate	JJ	appropriate
due	JJ	due
to	IN	to
their	PRP$	their
hypotension	NN	hypotension
properties	NNS	property
.	.	.
</s>
<s type="decl">
Opioids	NNS	opioid
may	MD	may
induce	VB	induce
mast	NN	mast
cell	NN	cell
degeneration	NN	degeneration
,	,	,
which	WDT	which
may	MD	may
worsen	VB	worse
the	DT	the
anaphylaxis	NN	anaphylaxis
.	.	.
</s>
<s type="sub">
Beta-blockers	NNS	beta-blocker
should	MD	should
be	VB	be
used	VBN	use
with	IN	with
extreme	JJ	extreme
caution	NN	caution
because	IN	because
they	PRP	they
can	MD	can
exaggerate	VB	exaggerate
coronary	JJ	coronary
spasms	NNS	spasm
and	CC	and
cause	VB	cause
epinephrine	NN	epinephrine
to	TO	to
be	VB	be
ineffective	JJ	ineffective
.	.	.
</s>
<s type="decl">
Epinephrine	NNP	Epinephrine
is	VBZ	be
the	DT	the
only	JJ	only
life-saving	JJ	life-saving
drug	NN	drug
in	IN	in
the	DT	the
event	NN	event
of	IN	of
aggravated	VBN	aggravate
ischemia	NN	ischemia
,	,	,
vasospasm	NN	vasospasm
,	,	,
and	CC	and
arrhythmias	NN	arrhythmia
.	.	.
</s>
<s type="decl">
In	IN	in
some	DT	some
animal	NN	animal
studies	NNS	study
,	,	,
adrenaline	NN	adrenaline
may	MD	may
cause	VB	cause
LV	NN	LV
impairment	NN	impairment
and	CC	and
not	RB	not
recovery	NN	recovery
in	IN	in
established	VBN	establish
anaphylactic	JJ	anaphylactic
shock	NN	shock
.	.	.
</s>
<s type="decl">
Therefore	RB	therefore
,	,	,
adrenaline	NN	adrenaline
is	VBZ	be
only	RB	only
suggested	VBN	suggest
in	IN	in
high-grade	JJ	high-grade
anaphylactic	JJ	anaphylactic
reactions	NNS	reaction
.	.	.
</s>
<s type="frag">
Adequate	JJ	Adequate
fluids	NNS	fluid
</s>
<s type="decl">
resuscitation	NN	resuscitation
and	CC	and
oxygen	NN	oxygen
therapy	NN	therapy
are	VBP	be
important	JJ	important
supportive	JJ	supportive
treatments	NNS	treatment
for	IN	for
Kounis	NNP	Kounis
syndrome	NN	syndrome
.	.	.
</s>
<s type="decl">
Type	NN	type
II	CD	II
variant	NN	variant
patients	NNS	patient
can	MD	can
take	VB	take
advantage	NN	advantage
of	IN	of
an	DT	a
ACS	NNP	ACS
protocol	NN	protocol
.	.	.
</s>
<s type="decl">
Double	JJ	double
antiplatelet	NN	antiplatelet
therapy	NN	therapy
in	IN	in
the	DT	the
pharmacological	JJ	pharmacological
treatment	NN	treatment
of	IN	of
myocardial	JJ	myocardial
revascularization	NN	revascularization
is	VBZ	be
suggested	VBN	suggest
,	,	,
including	VBG	include
acetylsalicylic	JJ	acetylsalicylic
acid	NN	acid
(	-LRB-	(
ASA	NNP	ASA
)	-RRB-	)
and	CC	and
another	DT	another
P2Y12	NNP	P2Y12
receptor	NN	receptor
inhibitor	NN	inhibitor
.	.	.
</s>
<s type="decl">
In	IN	in
the	DT	the
type	NN	type
III	CD	III
variant	NN	variant
,	,	,
the	DT	the
ACS	NNP	ACS
protocol	NN	protocol
accompanied	VBN	accompany
by	IN	by
urgent	JJ	urgent
aspiration	NN	aspiration
of	IN	of
intrastent	JJ	intrastent
thrombus	NN	thrombus
is	VBZ	be
suggested	VBN	suggest
(	:	(
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
5	CD	5
</s>
</figure>
<s type="frag">
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Antihistamines	NNS	Antihistamine
,	,	,
corticosteroids	NNS	corticosteroid
,	,	,
and	CC	and
mast	NN	mast
cell	NN	cell
stabilizers	NNS	stabilizer
may	MD	may
be	VB	be
helpful	JJ	helpful
for	IN	for
allergic	JJ	allergic
symptoms	NNS	symptom
after	IN	after
stent	NN	stent
implantation	NN	implantation
or	CC	or
revascularization	NN	revascularization
.	.	.
</s>
</p>
</text>